Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-06-28
1998-05-26
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514866, 530324, A61K 3800, A61K 3816, C07K 1400
Patent
active
057564612
ABSTRACT:
This invention describes methods of treating or preventing diabetes in obese type II diabetic patients. Specifically, methods of treating obese type II diabetics with varying levels of endogenous circulating leptin are claimed.
REFERENCES:
MacDougald et al. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. Sep. 1995, vol. 92, pp. 9034-9037.
HE et al. The Mouse obese Gene. The Journal of Biological chemistry. 1 Dec. 1995, vol. 270, No. 48, pp. 28887-28891.
Berkow et al. Merck Manual, New Jersey: Merck Research Laboratories. 1992, vol. 16, pp. 1106-1109.
Chem. Abstract 94-304407/38, Nagata Sangyo Co. Ltd. (Mar. 29, 1993).
Zhang, et al., "Positional cloning of the mouse obese gene and its human homologue", Nature, 372:1, 425-432 (Dec. 1, 1994).
Rink, "In Search of a satiety factor", Nature 372:1, 406-407 (Dec. 1, 1994).
Flam, "Obesity Gene Discovery May Help Sove Weighty Problem", Science 266, 1477-1478 (Dec. 2, 1994).
Hodgson, "Obesity" Where Less is More, Bio/Technology 13, 1060-1063 (Oct. 1995).
Stephens, et al., "The role of neuropeptide Y in the antiobesity action of the obese gene product", Nature 377, 530-532 (Oct. 12, 1995).
Masuzaki, et al., "Human Obese Gene Expression", Diabetes, 44 855-858 (Jul. 1995).
Barinaga, "Obese" Protein Slims Mice, Science 269, 475,-476 (Jul. 28, 1995).
Weigle, et al., "Recominant ob Protein Reduces feeding and Body Weight in the ob/ob Mouse", J. Clin. Invest. 96 2065-2070 (Oct. 1995).
Murakami, et al., "Cloning of Rat Obese cDNA and Its Expression in Obese Rats.sup.+ ",Biochemical and Biophysical Research Communications 209:3 944-952 (Apr. 26, 1995).
Campfield, et al., "Recominant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural Networks",Science 269, 546-549 (Jul. 28, 1995).
Considine, et al., "Evidence Against Either a Premature Stop Codon or the Absence of Obese Gene mRNA in Human Obesity", J. Clin. Invest. 95, 2985-2988 (Jun. 1995).
Pelleymounter, et al., "Effects of the Obese Gene Product on Body Weight Regulation in ob/ob Mice", Science 269, 540-543 (Jul. 28, 1995).
Halaas, et al., "Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene", Science 269, 543-546 (Jul. 18, 1995).
Zarjevski, et al., "Chronic Intracerebroventricular Neuropeptide-Y Administration to Normal Rats Mimics Hormonal and Metabolic Changes of Obesity", Endocrinology, vol. 133, No. 4 (1993).
Jeanrenaud, B., "An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause", Diabetologia (1985) 28:502-513.
Jeanrenaud, B., Central nervous system and peripheral abnormalities: clues 2!: S169-S178.
Jeanrenaud, B., "Neuroendocrine and Metabolic Basis of Type II Diabetes as Studied in Animal Models", Diabetes Metabolism Reviews, vol. 4 No. 6, 603-614 (1988).
Boone David E.
Borin Michael
Eli Lilly and Company
Maciak Ronald S.
Tsang Cecilia J.
LandOfFree
Methods for treating diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960083